Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research.

Current Issue

March-April 2023 (Vol. 20 Issue 2) Table of Contents
Cancer Genomics - Proteomics: 20 (2)

Issue highlights

  • An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms
  • Oncogenes and Methionine Addiction of Cancer: Role of c-MYC
  • Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells
  • Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
  • Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets

Special Issue on Emerging Technologies in Cancer Research


High-throughput genomic technologies continuously advance and offer new opportunities to better understand and treat cancer. The past decade has seen a plethora of next-generation sequencing and data analysis studies, allowing us to map the genomic landscapes of various cancer types, while single cell analyses are shedding light on tumor heterogeneity. Groundbreaking new technologies, such as spatial omics, can give us unprecedented insight into the spatiotemporal tumor architecture and micro-environment. In this regard, this special issue aims to bring together review articles, experimental and clinical studies on the following topics:

- Whole-genome sequencing

- Single-cell genomics

- Mutational signatures

- Spatial transcriptomics

- Epigenomics

- Multi-omics

- Tumor architecture

- Tumor progression

- Data analysis methods / bioinformatics /machine learning

- Tumor heterogeneity

- Circulating tumor cells

- Precision medicine

- Tumor microenvironment interactions

- Computational immunology

- New therapeutic targets

 Publication date: December 1, 2023; Submission deadline: November 3, 2023.

 Instructions for the preparation and submission of reviews and original articles.


 

Featured Articles

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human...
    September 04, 2017
  • The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan
    April 25, 2018
  • Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor...
    October 28, 2019
  • WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    December 26, 2015
  • Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical...
    December 26, 2015
  • ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and...
    March 01, 2018

Latest Articles

  • Open Access
    Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
    IOANNIS PANAGOPOULOS, KRISTIN ANDERSEN, LUDMILA GORUNOVA, MARIUS LUND-IVERSEN, INGVILD LOBMAIER, FRANCESCA MICCI and SVERRE HEIM
    Cancer Genomics & Proteomics March 2023, 20 (2) 171-181; DOI: https://doi.org/10.21873/cgp.20372
  • Open Access
    Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in Preclinical In Vivo Models
    ULRICH H. WEIDLE and FABIAN BIRZELE
    Cancer Genomics & Proteomics March 2023, 20 (2) 117-131; DOI: https://doi.org/10.21873/cgp.20368
  • Open Access
    Oncogenes and Methionine Addiction of Cancer: Role of c-MYC
    YUSUKE AOKI, QINGHONG HAN, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics March 2023, 20 (2) 165-170; DOI: https://doi.org/10.21873/cgp.20371
  • Open Access
    Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
    AKINORI MINATO, YUZAN KUDO, HIROTSUGU NOGUCHI, SHIRO KOHI, YOSHITAKA HASEGAWA, NORIHIRO SATO, KEIJI HIRATA and NAOHIRO FUJIMOTO
    Cancer Genomics & Proteomics March 2023, 20 (2) 203-210; DOI: https://doi.org/10.21873/cgp.20375
  • Open Access
    An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms
    JAMES SALLER, DALEY WHITE, BROOKE HOUGH, SEAN YODER, JUNMIN WHITING, DUNG-TSA CHEN, ANTHONY MAGLIOCCO and DOMENICO COPPOLA
    Cancer Genomics & Proteomics March 2023, 20 (2) 154-164; DOI: https://doi.org/10.21873/cgp.20370
  • Open Access
    Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics March 2023, 20 (2) 132-153; DOI: https://doi.org/10.21873/cgp.20369
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Access CGP at your Mobile Device

Now you can access the entire contents of Cancer Genomics & Proteomics at your Android or iOS device with our newly designed mobile app, freely available through Google Play and App Store.

Visit the official website of Cancer Genomics & Proteomics.
Back to top
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire